Log on / register
Feedback | Support | My details

Comments

Rationale and design of PROSPECT-CONKO 004: a prospective, randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy)

Hanno Riess* email, Uwe Pelzer* email, Andreas Hilbig email, Jens Stieler email, Bernhard Opitz email, Theo Scholten email, Dörte Kauschat-Brüning email, Peter Bramlage email, Bernd Dörken email and Helmut Oettle email

BMC Cancer 2008, 8:361doi:10.1186/1471-2407-8-361

No comments have yet been made on this article

Post a comment

Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.